Impact of Routine Angiographic Follow-Up on the Clinical Benefits of Paclitaxel-Eluting Stents. Results From the TAXUS-IV Trial

Journal of the American College of Cardiology

Volumn 48, Issue 1, 2006, Pages 32-36

  Pinto, Duane S ^a   Stone, Gregg W ^b   Ellis, Stephen G ^c   Cox, David A ^d   Hermiller, James ^e   O'Shaughnessy, Charles ^f   Mann, J Tift ^g   Mehran, Roxana ^b   Na, Yingbo ^b   Turco, Mark ^h   Caputo, Ronald ⁱ   Popma, Jeffrey J ^j   Cutlip, Donald E ^a   Russell, Mary E ^k   Cohen, David J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Mid Carolina Cardiology   (United States)

^e ST VINCENT HOSPITAL   (United States)

^f Elyria Memorial Hospital   (United States)

^g WAKEMED HEALTH AND HOSPITALS   (United States)

^h WASHINGTON ADVENTIST HOSPITAL   (United States)

ⁱ St Joseph's Hospital   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k BOSTON SCIENTIFIC CORPORATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METAL; PACLITAXEL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; DRUG FATALITY; EVALUATION; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE; RESTENOSIS; STATISTICAL ANALYSIS; TARGET ORGAN; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METALS; MIDDLE AGED; PACLITAXEL; STENTS;

EID: 33745285306     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.02.060     Document Type: Article

References (8)

1. Gruentzig A., Senning A., and Siegenthaler W. Nonoperative dilatation of coronary-artery stenosis. percutaneous transluminal coronary angioplasty. N Engl J Med 301 (1979) 61-68
2. Holmes D.R., Kip K.E., Yeh W., Kelsey S.F., Detre K.M., and Williams D.O. Long-term analysis of conventional coronary balloon angioplasty and an initial "stent-like" result. the NHLBI PTCA registry. J Am Coll Cardiol 32 (1998) 590-595
3. Morice M.-C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
4. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
5. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
6. Cutlip D.E., Chauhan M.S., Baim D.S., et al. Clinical restenosis after coronary stenting. perspectives from multicenter clinical trials. J Am Coll Cardiol 40 (2002) 2082-2089
7. Serruys P.W., van Hout B., Bonnier H., et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease. (Benestent II). Lancet 352 (1998) 673-681
8. Stone G.W., Grines C.L., Cox D.A., et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346 (2002) 957-966